These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
119 related items for PubMed ID: 3151346
41. Comparative bioavailability of two oral formulations of ciprofloxacin. Trejo D, Toledo A, Carrasco-Portugal Mdel C, Aguilar-Cota ME, Herrera JE, Flores-Murrieta FJ. Proc West Pharmacol Soc; 2003; 46():134-5. PubMed ID: 14699910 [No Abstract] [Full Text] [Related]
42. In vivo tissue pharmacokinetics by fluorine magnetic resonance spectroscopy: a study of liver and muscle disposition of fleroxacin in humans. Jynge P, Skjetne T, Gribbestad I, Kleinbloesem CH, Hoogkamer HF, Antonsen O, Krane J, Bakøy OE, Furuheim KM, Nilsen OG. Clin Pharmacol Ther; 1990 Nov; 48(5):481-9. PubMed ID: 2121409 [Abstract] [Full Text] [Related]
50. Effect of probenecid on the distribution and elimination of ciprofloxacin in humans. Jaehde U, Sörgel F, Reiter A, Sigl G, Naber KG, Schunack W. Clin Pharmacol Ther; 1995 Nov; 58(5):532-41. PubMed ID: 7586947 [Abstract] [Full Text] [Related]
53. Population pharmacokinetics and use of Monte Carlo simulation to evaluate currently recommended dosing regimens of ciprofloxacin in adult patients with cystic fibrosis. Montgomery MJ, Beringer PM, Aminimanizani A, Louie SG, Shapiro BJ, Jelliffe R, Gill MA. Antimicrob Agents Chemother; 2001 Dec; 45(12):3468-73. PubMed ID: 11709326 [Abstract] [Full Text] [Related]
55. Disposition of fleroxacin, a new trifluoroquinolone, and its metabolites. Pharmacokinetics in renal failure and influence of haemodialysis. Singlas E, Leroy A, Sultan E, Godin M, Moulin B, Taburet AM, Dhib M, Fillastre JP. Clin Pharmacokinet; 1990 Jul; 19(1):67-79. PubMed ID: 2116256 [Abstract] [Full Text] [Related]
56. Single-dose pharmacokinetic study of ciprofloxacin and fleroxacin in healthy adult Nigerian volunteers. Chukwuani CM, Coker HA, Oduola AM, Ifudu ND, Sowunmi A. Chemotherapy; 1998 Jul; 44(6):369-76. PubMed ID: 9755295 [Abstract] [Full Text] [Related]
57. Pharmacokinetic properties and oral bioavailabilities of difloxacin in pig and chicken. Inui T, Taira T, Matsushita T, Endo T. Xenobiotica; 1998 Sep; 28(9):887-93. PubMed ID: 9764930 [Abstract] [Full Text] [Related]
59. Comparative oral pharmacokinetics of fleroxacin and pefloxacin. De Lepeleire I, Van Hecken A, Verbesselt R, Tjandra-Maga TB, De Schepper PJ. J Antimicrob Chemother; 1988 Aug; 22(2):197-202. PubMed ID: 3141343 [Abstract] [Full Text] [Related]
60. Pharmacokinetics and biliary concentrations of fleroxacin in cholecystectomized patients. Hayton WL, Vlahov V, Bacracheva N, Viachki I, Portmann R, Muirhead G, Stoeckel K, Weidekamm E. Antimicrob Agents Chemother; 1990 Dec; 34(12):2375-80. PubMed ID: 2128442 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]